Pharma Glass Vials - Type I: Market Size & Forecast 2026

The global Type I borosilicate pharmaceutical glass vials market reached approximately USD 5.8 billion in 2025 (base year), growing at 6.2 percent CAGR through 2032 to a forecast endpoint of roughly USD 8.8 billion. The market sits in a structurally tight balance: biologics and vaccine demand is running ahead of conversion capacity for tubular vials, while borosilicate glass tubing remains concentrated in a narrow set of specialised melt facilities across Europe and Japan. The reference unit economics for a standard tubular 2R-10R Type I vial run at approximately USD 0.18 per unit at the converter level, of which 42 percent traces to the borosilicate glass tubing feedstock purchased from primary glass producers. The Buyer Power Score for this category is -2.0 on the -5.0 to +5.0 scale, indicating a supplier-favoring market. > **Analyst Take.** The consensus 6.2 percent CAGR is directiona

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.